MVIS US Listed Biotech 25 Index

The MVIS US Listed Biotech 25 Index (MVBBH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the biotech industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from biotech related products and services, such as research and development, production, or marketing and sales of drugs based on genetic analysis and diagnostic equipment.

Financial Products

A licence agreement is required to use our indices, index data or trademark for any commercial purpose, or for research and analysis, or for the issuance, launch, promotion or marketing of financial products such as exchange-traded products, mutual funds, certificates, derivatives, swaps, bonds or OTC products linked to or based on MVIS indices. Please contact us for information on obtaining a licence.

The MVIS US Listed Biotech 25 Index Index is currently licensed to underlie the following products:

  • VanEck Biotech ETF